Senzar Asset Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Senzar Asset Management’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-775,890	Closed	-$10M	–	30
2018 Q1	$10M	Sell	775,890 -953,977	-55%	-$11.9M	3.16%	14
2017 Q4	$21.7M	Buy	1,729,867 +1,124,509	+186%	+$14.7M	5.54%	6
2017 Q3	$8M	Buy	+605,358	New	+$8.33M	1.95%	15
2015 Q1	–	Sell	-933,469	Closed	-$12M	–	39
2014 Q4	$12M	Buy	+933,469	New	+$10.7M	3.51%	9
2014 Q1	–	Sell	-458,735	Closed	-$4.46M	–	22
2013 Q4	$4.46M	Buy	+458,735	New	+$4.12M	3.64%	12

Other funds holding IRWD

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Senzar Asset Management's IRWD Position: Q2 2018 in Review

Senzar Asset Management sold out of Ironwood Pharmaceuticals (IRWD) in Q2 2018, closing a stake of 775,890 shares — an estimated $10M sold.

Senzar Asset Management first reported a position in IRWD in Q4 2013 and held it in 5 quarters. The position peaked at $21.7M in Q4 2017. 148 funds tracked by Wall St. Rank hold IRWD as of Q2 2018.

Senzar Asset Management reported no remaining Ironwood Pharmaceuticals position as of Q2 2018 after selling out during the quarter.
Senzar Asset Management sold 775,890 Ironwood Pharmaceuticals shares in Q2 2018, an estimated $10M.
Senzar Asset Management first reported a position in Ironwood Pharmaceuticals in Q4 2013 and held it in 5 quarters.
Senzar Asset Management's Ironwood Pharmaceuticals position peaked at $21.7M in Q4 2017.
148 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2018.

Based on Senzar Asset Management's 13F filing for Q2 2018, filed 13 Aug 2018.